Sup Fig 2 from Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia
Year: 2023
Type: other
Abstract: DHA treatment abrogates MCL-1 protein expression by post-transcriptional mechanism
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361885787
